Search Results
You are looking at 1 - 1 of 1 items for
- Author: Gabriella Guelfi x
- Refine by access: All content x
Search for other papers by Massimo Zerani in
Google Scholar
PubMed
Search for other papers by Francesco Parillo in
Google Scholar
PubMed
Search for other papers by Gabriele Brecchia in
Google Scholar
PubMed
Search for other papers by Gabriella Guelfi in
Google Scholar
PubMed
Search for other papers by Cecilia Dall'Aglio in
Google Scholar
PubMed
Search for other papers by Lorena Lilli in
Google Scholar
PubMed
Search for other papers by Margherita Maranesi in
Google Scholar
PubMed
Search for other papers by Anna Gobbetti in
Google Scholar
PubMed
Search for other papers by Cristiano Boiti in
Google Scholar
PubMed
The expression of type I GNRH receptor (GNRHR-I) and the direct role of GNRH-I on corpora lutea (CL) function were studied in the pseudopregnant rabbit model. Immunohistochemistry evidenced GNRHR-I and GNRH-I in luteal cells at early (day 4 pseudopregnancy)-, mid (day 9)-, and late (day 13)-luteal stages. Real-time RT-PCR and western blotting revealed GNRHR-I mRNA and protein at the three luteal stages. Buserelin in vivo treatment at days 9 and 13 decreased plasma progesterone levels for 48 and 24 h respectively. In in vitro cultured CL, buserelin reduced progesterone secretion, increased prostaglandin F2 α (PGF2 α) secretion and cyclo-oxygenase-2 (COX-2) and nitric oxide synthase (NOS) activities at days 9 and 13, and decreased PGE2 at day 13. Co-incubation with antagonists for GNRH-I (antide), inositol 1,4,5-trisphosphate (IP3, 2-amino-ethoxydiphenylborate), and diacylglycerol (DAG, 1-hexadecyl-2-acetyl glycerol) or inhibitors for phospholipase C (PLC, compound 48/80), and protein kinase C (PKC, staurosporine) counteracted the buserelin effects. Buserelin co-incubated with COX inhibitor (acetylsalicylic acid) increased progesterone and decreased PGF2 α and NOS activity at days 9 and 13, whereas co-incubation with NOS inhibitor (N-nitro-l-arginine methyl ester) increased progesterone at the same luteal stages. These results suggest that GNRHR-I is constitutively expressed in rabbit CL independently of luteal stage, whereas GNRH-I down-regulates directly CL progesterone production via PGF2 α at mid- and late-luteal stages of pseudopregnancy, utilizing its cognate type I receptor with a post-receptorial mechanism that involves PLC, IP3, DAG, PKC, COX-2, and NOS.
